We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
(-18%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$9.86M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$9.7M |
| 3 |
CNR
Core Natural Resources Inc
CNR
|
+$8.26M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$6.63M |
| 5 |
Oracle
ORCL
|
+$6.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$14M |
| 2 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$11.1M |
| 3 |
NVIDIA
NVDA
|
+$9.36M |
| 4 |
Amazon
AMZN
|
+$8.75M |
| 5 |
Netflix
NFLX
|
+$8.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.2% |
| 2 | Healthcare | 10.48% |
| 3 | Consumer Discretionary | 9.93% |
| 4 | Financials | 7.26% |
| 5 | Communication Services | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.47B
| $1.05M | 0.08% |
+28,910
| New | +$1.05M |
|
|
PLYA
302
DELISTED
Playa Hotels & Resorts
PLYA
| $1.03M | 0.08% |
+77,414
| New | +$1M |
|
303
Turning Point Brands
TPB
$1.81B
| $1.02M | 0.08% |
+17,182
| New | +$1.06M |
|
304
Terreno Realty
TRNO
$7.42B
| $1.02M | 0.08% |
16,078
-596
| -4% | -$38.7K |
|
305
Wingstop
WING
$3.21B
| $1.02M | 0.08% |
4,504
+961
| +27% | +$250K |
|
306
Cogent Biosciences
COGT
$7.1B
| $1.01M | 0.08% |
+169,449
| New | +$1.33M |
|
307
Evergy
EVRG
$19B
| $1.01M | 0.08% |
14,716
-14,872
| -50% | -$973K |
|
308
Triple Flag Precious Metals
TFPM
$6.63B
| $1.01M | 0.08% |
52,944
+15
| +0% | +$256 |
|
309
CALL
Chevron
CVX
$378B
| $1M | 0.08% |
6,000
+4,000
| +200% | +$626K |
|
|
DM
310
DELISTED
Desktop Metal, Inc.
DM
| $998K | 0.08% |
203,252
| – | – |
|
311
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
| $995K | 0.08% |
10,929
-23,001
| -68% | -$2.05M |
|
312
Apollo Global Management
APO
$74.1B
| $983K | 0.07% |
7,181
+3,562
| +98% | +$548K |
|
313
GE Aerospace
GE
$380B
| $975K | 0.07% |
4,871
+1,859
| +62% | +$366K |
|
|
AKRO
314
DELISTED
Akero Therapeutics
AKRO
| $971K | 0.07% |
23,990
+6,118
| +34% | +$259K |
|
315
Dyne Therapeutics
DYN
$4.92B
| $969K | 0.07% |
+92,652
| New | +$1.33M |
|
|
SLNO
316
DELISTED
Soleno Therapeutics
SLNO
| $959K | 0.07% |
13,423
-6,893
| -34% | -$336K |
|
317
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $959K | 0.07% |
+10,581
| New | +$958K |
|
318
Oppenheimer Holdings
OPY
$1.2B
| $954K | 0.07% |
16,000
| – | – |
|
319
OR Royalties Inc
OR
$6.27B
| $946K | 0.07% |
44,781
-1,399
| -3% | -$26.9K |
|
320
Xponential Fitness
XPOF
$206M
| $945K | 0.07% |
113,446
+62,949
| +125% | +$878K |
|
|
MASI
321
DELISTED
Masimo
MASI
| $943K | 0.07% |
+5,659
| New | +$982K |
|
322
Brinker International
EAT
$9.67B
| $933K | 0.07% |
+6,259
| New | +$963K |
|
|
323
PUT
Netflix
NFLX
$316B
| $933K | 0.07% |
10,000
-1,000
| -9% | -$95.1K |
|
324
iShares MSCI Hong Kong ETF
EWH
$1.23B
| $928K | 0.07% |
53,000
| – | – |
|
325
CALL
Crown Castle
CCI
$31.4B
| $928K | 0.07% |
8,900
| – | – |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.
- Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
- Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
- Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
- Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
- Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
- Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
- Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.
Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.